ɐdmˈɪnɪstɚɹɪŋ ɡɹˈoʊθ hˈoːɹmoʊn, ðˈɛɹfoːɹ, hɐz lˈɪɾəl ɔːɹ nˈoʊ ɪfˈɛkt ɔnðə ɡɹˈoʊθ ʌvðɪ ˌɪndᵻvˈɪdʒuːəl wɪð pɹɪmˈoːɹdɪəl dwˈɔːɹfɪzəm, ɛksˈɛpt ɪnðə kˈeɪs ʌv ɹˈʌsəl sˈɪlvɚ sˈɪndɹoʊm ˌɑːɹɹˌɛsˈɛs.
Administering growth hormone, therefore, has little or no effect on the growth of the individual with primordial dwarfism, except in the case of Russell–Silver syndrome (RSS).